Ariel Yaar

Angel investor in Israel

Invests in AI

Ariel Yaar's investor profile lists AI alongside Fintech, Healthcare & Biotech and Digital Health & HealthTech, at pre-seed and seed. The record holds 5 deals, among them BioChange Ltd., GearEye and DermaDetect.

Email Investor

Email Investor

Credits to line up before a pre-seed round

Ariel Yaar backs companies at pre-seed and seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • BioChange Ltd.
  • GearEye
  • DermaDetect
  • Readz
  • Glassbox

Investment focus

Backs startups in
Artificial Intelligence, Fintech, Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma, MedTech & Medical Devices and 4 more
Rounds
Pre-seed, Seed
Profile
Angel investor
Deals on record
5
Based in
Israel

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Ariel Yaar invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Ariel Yaar's investor profile, together with Fintech, Healthcare & Biotech and Digital Health & HealthTech. The stages on record are pre-seed and seed.
Which companies has Ariel Yaar backed?
The record lists 5 deals, including BioChange Ltd., GearEye, DermaDetect, Readz and Glassbox. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Ariel Yaar?
For a company raising a pre-seed round, AI Perks lists credits such as Vercel (up to $850,000), Algolia (up to $10,000), Amazon Bedrock (up to $200,000) and AssemblyAI (up to $150,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor